NDC 70771-1057 – Acamprosate calcium

Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Oral

Human Prescription Drug

Product NDC70771-1057

Product details

Brand name
Acamprosate calcium
Generic name
Acamprosate calcium
Labeler
Zydus Lifesciences Limited
Dosage form
Tablet, Delayed Release
Route
Oral
Marketing category
ANDA · ANDA205995
Marketed since
June 1, 2017
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Acamprosate Calcium →

Package NDC codes (6)

Package NDCDescriptionSince
70771-1057-01000 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-0)Jun 1, 2017
70771-1057-1100 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-1)Jun 1, 2017
70771-1057-330 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-3)Jun 1, 2017
70771-1057-5500 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-5)Jun 1, 2017
70771-1057-8180 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-8)Jun 1, 2017
70771-1057-990 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-9)Jun 1, 2017

Other Acamprosate Calcium products